Intermittent Vismodegib Shows Good Activity in Basal Cell Carcinoma
There was good activity among patients with multiple basal cell carcinomas who were treated with two intermittent vismodegib dosing regimens.
All articles by Jason Hoffman
Skin Cancer Risk Factors Among Transplant Recipients
There’s a higher risk of skin cancer following organ transplantation with increased age, being Caucasian or male.
Adjuvant Treatment with Ipilimumab Doesn’t Improve HRQoL in Stage III Melanoma
In patients with stage-III melanoma, adjuvant treatment with ipilimumab did not worsen HRQoL.
Melanoma Survivors Report Increased Sun Exposure
Some melanoma survivors say that indoor tanning and getting sunburns is associated with skin cancer.
Stillbirth, Neonatal Death Linked to Maternal Cancer During Pregnancy
Maternal cancer during pregnancy is linked with higher risks of stillbirth and neonatal mortality.
Binimetinib Prolongs Survival in NRAS-Mutant Melanoma
Binimetinib prolonged progression-free survival and was associated with a safety profile for patients with NRAS-mutant melanoma.
Mutation Incidence Low in Cutaneous Squamous Cell Carcinoma
In patients with cutaneous squamous cell carcinoma, incidence of RAS, BRAF, and EGFR are low.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...